1. Zp1609
1. 943134-39-2
2. Gap-134
3. (2s,4r)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid
4. Danegaptida
5. Zp1609
6. Pa0y7735at
7. Zp-1609
8. Glycyl-(4r)-4-(benzoylamino)-l-proline
9. L-proline, Glycyl-4-(benzoylamino)-, (4r)-
10. Dtxsid201026039
11. (2s,4r)-1-(aminoacetyl)-4-(benzoylamino)pyrrolidine-2-carboxylic Acid
12. Danegaptidum
13. [2s,4r]-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid
14. Refchem:919625
15. Dtxcid301510295
16. 943134-39-2 (free Base)
17. (2s,4r)-4-benzamido-1-glycylpyrrolidine-2-carboxylic Acid
18. Mfcd16619374
19. Danegaptide [usan]
20. Danegaptide [usan:inn]
21. Unii-pa0y7735at
22. (2s,4r)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylicacid
23. Danegaptide [inn]
24. Danegaptide (usan/inn)
25. Danegaptide [who-dd]
26. Chembl560592
27. Schembl2399763
28. Bizkihujgmsvfd-mnovxskesa-n
29. Chebi:177853
30. Akos030527026
31. Cs-1100
32. Db11821
33. Hy-10913
34. Db-289821
35. Ns00072457
36. D09599
37. D95155
38. 134a392
39. Brd-k35589454-003-01-1
40. Q27286426
41. (2s,4r) 1-(2-amino-acetyl)-4-benzoylamino-pyrrolidine-2-carboxylic Acid
42. (2s,4r)-1-(2-azanylethanoyl)-4-benzamido-pyrrolidine-2-carboxylic Acid
43. (2s4r) 1-(2-amino-acetyl)-4-benzoylamino-pyrrolidine-2-carboxylic Acid
44. (2s4r)1-(2-amino-acetyl)-4-benzoylamino-pyrrolidine-2-carboxylic Acid
Molecular Weight | 291.30 g/mol |
---|---|
Molecular Formula | C14H17N3O4 |
XLogP3 | -2.7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 113 |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 420 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Danegaptide, a small modified dipeptide, is a selective second generation gap junction modifier with oral bioavailability. Danegaptide prevents postoperative atrial fibrillation (AF) and chronic AF in large animal models. In a canine model of acute sterile pericarditis, Danegaptide significantly reduced AF duration and overall AF burden. Danegaptide has a similar mechanism of action to its parent compound rotigaptide. Rotigaptide is a synthetic antiarrhythmic peptide (AAP) analogue which has been tested in vitro which shows prevention of prevents metabolic stress-induced atrial conduction velocity (CV) and rapidly reverts established atrial CV slowing. Rogitapeptide enhances gap junction conductance and coupling, increasing the amount of small molecules such as ions, metabolites and secondary messengers passing from one cell to another.